Financials Bactiguard Holding AB

Equities

BACTI B

SE0005878741

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:23:33 2024-05-06 am EDT 5-day change 1st Jan Change
71.8 SEK -0.28% Intraday chart for Bactiguard Holding AB +3.16% +16.18%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 3,869 2,166 2,516 - -
Enterprise Value (EV) 1 3,869 2,276 2,698 2,692 2,639
P/E ratio -73.1 x -15.6 x -42.5 x -108 x 53.2 x
Yield - - - - -
Capitalization / Revenue - 9.7 x 11.3 x 10.6 x 8.22 x
EV / Revenue - 10.2 x 12.1 x 11.3 x 8.62 x
EV / EBITDA - -29.9 x -169 x 71.3 x 29.7 x
EV / FCF - - -37.5 x 2,692 x 67.7 x
FCF Yield - - -2.67% 0.04% 1.48%
Price to Book - - 8.56 x 9.65 x 7.79 x
Nbr of stocks (in thousands) 35,044 35,044 35,044 - -
Reference price 2 110.4 61.80 71.80 71.80 71.80
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 223.2 223 237.8 306
EBITDA 1 - -76.07 -15.93 37.72 89
EBIT 1 - -131.9 -51 -13.95 63
Operating Margin - -59.12% -22.87% -5.87% 20.59%
Earnings before Tax (EBT) 1 - -147.2 -64 -24.48 50
Net income 1 -52.88 -138.4 -59 -23.22 47
Net margin - -62.01% -26.46% -9.77% 15.36%
EPS 2 -1.510 -3.950 -1.690 -0.6650 1.350
Free Cash Flow 1 - - -72 1 39
FCF margin - - -32.29% 0.42% 12.75%
FCF Conversion (EBITDA) - - - 2.65% 43.82%
FCF Conversion (Net income) - - - - 82.98%
Dividend per Share 2 - - - - -
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 58.79 53 54 58
EBITDA 1 -1.501 -6 -2 5
EBIT 1 -12.87 -18 -14 -7
Operating Margin -21.89% -33.96% -25.93% -12.07%
Earnings before Tax (EBT) 1 -12.2 -22 -18 -11
Net income 1 -9.901 -21 -17 -11
Net margin -16.84% -39.62% -31.48% -18.97%
EPS 2 -0.2800 -0.6000 -0.5000 -0.3100
Dividend per Share - - - -
Announcement Date 4/25/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 110 182 175 123
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - -1.445 x -11.42 x 4.651 x 1.382 x
Free Cash Flow 1 - - -72 1 39
ROE (net income / shareholders' equity) - -32.6% -18.3% -10.9% 15.8%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - 8.390 7.440 9.220
Cash Flow per Share - - - - -
Capex 1 - 7.19 12 10 12
Capex / Sales - 3.22% 5.38% 4.21% 3.92%
Announcement Date 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. BACTI B Stock
  4. Financials Bactiguard Holding AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW